ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 130 filers reported holding ANAPTYSBIO INC in Q1 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $647 | -34.6% | 36,069 | -25.9% | 0.00% | -100.0% |
| Q2 2023 | $990 | +32.4% | 48,662 | +41.6% | 0.00% | – |
| Q1 2023 | $748 | -40.2% | 34,354 | -14.9% | 0.00% | -100.0% |
| Q4 2022 | $1,250 | -99.9% | 40,351 | -17.3% | 0.00% | 0.0% |
| Q3 2022 | $1,244,000 | +5823.8% | 48,773 | +4691.1% | 0.00% | – |
| Q2 2022 | $21,000 | -73.8% | 1,018 | -68.3% | 0.00% | – |
| Q1 2022 | $80,000 | -95.1% | 3,213 | -93.1% | 0.00% | – |
| Q4 2021 | $1,626,000 | +409.7% | 46,806 | +299.1% | 0.00% | – |
| Q3 2021 | $319,000 | +228.9% | 11,729 | +214.9% | 0.00% | – |
| Q2 2021 | $97,000 | -79.0% | 3,725 | -82.6% | 0.00% | – |
| Q1 2021 | $461,000 | +191.8% | 21,399 | +190.0% | 0.00% | – |
| Q4 2020 | $158,000 | -45.9% | 7,379 | -62.8% | 0.00% | – |
| Q3 2020 | $292,000 | -45.3% | 19,840 | -17.0% | 0.00% | – |
| Q2 2020 | $534,000 | -78.8% | 23,892 | -86.6% | 0.00% | -100.0% |
| Q1 2020 | $2,518,000 | +440.3% | 178,271 | +520.8% | 0.00% | – |
| Q4 2019 | $466,000 | -52.6% | 28,715 | +2.1% | 0.00% | -100.0% |
| Q3 2019 | $984,000 | -47.4% | 28,121 | -15.1% | 0.00% | 0.0% |
| Q2 2019 | $1,870,000 | +26.2% | 33,139 | +63.4% | 0.00% | 0.0% |
| Q1 2019 | $1,482,000 | +0.7% | 20,281 | -12.1% | 0.00% | 0.0% |
| Q4 2018 | $1,472,000 | -94.9% | 23,074 | -92.1% | 0.00% | -95.2% |
| Q3 2018 | $29,033,000 | +939.1% | 290,992 | +640.0% | 0.02% | +600.0% |
| Q2 2018 | $2,794,000 | +36.4% | 39,325 | +99.8% | 0.00% | +50.0% |
| Q1 2018 | $2,048,000 | +618.6% | 19,681 | +595.4% | 0.00% | – |
| Q4 2017 | $285,000 | +2750.0% | 2,830 | +918.0% | 0.00% | – |
| Q3 2017 | $10,000 | -16.7% | 278 | -44.8% | 0.00% | – |
| Q2 2017 | $12,000 | -53.8% | 504 | -45.9% | 0.00% | – |
| Q1 2017 | $26,000 | – | 931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |